Assessing THK (TSE:6481) Valuation After Recent Share Price Pullback And Conflicting Fair Value Signals

Simply Wall St

Sun, February 15, 2026 at 8:08 AM GMT+9 4 min read

In this article:

6481

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Recent performance context for THK

With no single headline event setting the tone, THK (TSE:6481) has drawn attention through its recent share performance and fundamentals, giving investors fresh numbers to weigh against the broader capital goods sector.

Over the past month, the stock shows a 6% return, and about 16% over the past 3 months. On a 1 year view, the total return is about 34%, while the year to date figure stands near 12%.

Longer term holders are looking at total returns of roughly 78% over 3 years and 50% over 5 years. The latest close at ¥4,515 sets the reference point for any new analysis.

See our latest analysis for THK.

The share price has pulled back sharply in the very short term, with a 1 day share price return of about a 13% decline and a 7 day share price return of roughly a 10% decline. However, the 3 month share price return of about 16% and 1 year total shareholder return of roughly 34% still point to positive momentum over a longer horizon.

If this move in an industrial name has you thinking about where automation is heading next, it could be a good moment to scan our list of 31 robotics and automation stocks for other potential ideas.

So, with THK trading near its analyst price target and showing roughly 34% 1-year and 78% 3-year total returns, alongside an estimated 34% intrinsic discount, is this a fresh entry point, or is the market already pricing in future growth?

Most Popular Narrative: 1.7% Overvalued

THK’s most followed narrative pegs fair value at about ¥4,442, just below the last close of ¥4,515, which puts the current price slightly ahead of that view.

Management has committed to a comprehensive two-year structural reform to transform THK into a leaner, more profitable organization, targeting over 10% ROE through cost reduction, business selection, and productivity enhancements. These efforts are expected to directly improve operating income and net margins by FY 2027-2029.

Read the complete narrative.

Want to see what kind of earnings path and margin profile need to line up to support that valuation? The full narrative spells out the revenue runway, profitability reset, and future earnings multiple that sit behind this fair value call.

Result: Fair Value of ¥4,441.54 (OVERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, weaker industrial machinery orders in key regions, along with higher costs tied to structural reforms, could pressure margins and make the current fair value narrative harder to sustain.

Story Continues  

Find out about the key risks to this THK narrative.

Another View: DCF Points To A Different Story

While the consensus narrative suggests THK is about 1.7% overvalued at ¥4,515 versus a fair value of roughly ¥4,442, our DCF model paints a very different picture, with a future cash flow value closer to ¥6,806 per share, implying roughly a 34% discount. Which lens do you trust more when the signals conflict this sharply?

Look into how the SWS DCF model arrives at its fair value.

6481 Discounted Cash Flow as at Feb 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out THK for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 22 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own THK Narrative

If you look at the numbers and reach a different conclusion, or simply want to test your own view, you can build a complete THK story in just a few minutes. Start with Do it your way.

A great starting point for your THK research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If THK caught your eye, do not stop there. You may miss other opportunities sitting in plain sight if you do not look further.

Target quality at a discount by checking our list of 22 high quality undervalued stocks that combine solid fundamentals with room for potential re rating.

Strengthen your income stream by scanning 16 dividend fortresses that focus on higher yielding companies with robust payout profiles.

Dial down portfolio stress by reviewing 45 resilient stocks with low risk scores that screen for companies with more resilient risk scores.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include 6481.T.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info